Literature DB >> 10998044

Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization.

C Paul1, I Seiliez, J P Thissen, A Le Cam.   

Abstract

Suppressors of cytokine signalling (SOCS) represent a newly discovered family of molecules that seem to play an important role in the shutting off of cytokine and possibly peptide hormone action. Thus, understanding the mechanisms controlling their expression is of cardinal importance. In the present study, we have cloned the rat SOCS-3 gene and analyzed its expression and the functioning of its promoter in hepatocytes. Expression of SOCS-3 mRNA, which is very weak in freshly isolated cells, tended to increase when hepatocytes were incubated without hormones. Growth hormone (GH) and, to a much larger extent, interleukin-6 (IL-6) rapidly activated mRNA synthesis whereas glucocorticoids (GC) strongly inhibited both basal and hormone-dependent expressions. A short promoter fragment (-137/+35) responded maximally to GH and IL-6 (a threefold stimulation for each effector) and to GC (a 70-80% inhibition), whereas longer promoter sequences supported higher basal activity and lower positive hormonal responses. Deletion and mutation analyses indicated that all hormonal responses were dependent on two cis-acting sequences termed the G-rich and the A/T-rich elements. Only the A/T-rich element was active in a heterologous context, thus behaving as a typical enhancer. Unexpectedly, the two signal transducer and activator of transcription (STAT) binding sites found immediately upstream of the G-rich motif didn't seem to participate in either GH or IL-6 effect, despite the fact that one of them strongly responded to IL-6 when placed in front of a heterologous promoter. Finally, the negative regulation of SOCS-3 promoter by GC that may contribute to gene silencing in vivo, appeared to involve interactions of the GC receptor with other transcription factors and not direct binding to DNA, as no GC-response element was found in the sequence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998044     DOI: 10.1046/j.1432-1327.2000.01395.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.

Authors:  Hai Li Yang; Chan Sun; Chao Sun; Ren Li Qi
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

Review 3.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

4.  Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.

Authors:  M J Walsh; J R Jonsson; M M Richardson; G M Lipka; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

5.  Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.

Authors:  A E Karlsen; S G Rønn; K Lindberg; J Johannesen; E D Galsgaard; F Pociot; J H Nielsen; T Mandrup-Poulsen; J Nerup; N Billestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.

Authors:  F Schaefer; Y Chen; T Tsao; P Nouri; R Rabkin
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription.

Authors:  Dennis J Chia; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-08-11

8.  The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.

Authors:  Tieying Hou; Sutapa Ray; Chang Lee; Allan R Brasier
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

9.  In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes.

Authors:  Mark P Yeager; Patricia A Pioli; Kathleen Wardwell; Michael L Beach; Peter Martel; Hong K Lee; Athos J Rassias; Paul M Guyre
Journal:  Anesth Analg       Date:  2008-11       Impact factor: 5.108

10.  Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.

Authors:  Yoshihiro Miyanaka; Yoshitaka Ueno; Shinji Tanaka; Kyoko Yoshioka; Tsuyoshi Hatakeyama; Masaru Shimamoto; Masaharu Sumii; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.